Abstract: With the progress of medical technology, the number of patients receiving percutaneous pulmonary valve implantation (PPVI) has been increasing in recent years. At present, PPVI is considered to be a safe, effective and widely accepted new method for the treatment of RVOT dysfunction at home and abroad.Now, the Melody valve, the Sapien valve and the Venus-P valves are mainly used clinically, and different valves are selected according to the RVOT diameter size.Postoperative complications mainly include stent fracture, infectious endocarditis, coronary artery and aortic stenosis, valve embolism, pulmonary artery obstruction, etc.T his article reviews the current situation and future prospect of percutaneous pulmonary valve implantation in order to provide some theoretical basis for clinical treatment.